From: Humoral factors in ALS patients during disease progression
 | ALS patients | Healthy controls |
---|---|---|
n | 13 | 7 |
Age (years) mean ± SEM | 53.85 ± 2.81 | 57.71 ± 5.73 |
Range, 38–68 | Range, 37–69 | |
Sex (male/female) | 12/1 | 3/4 |
ALSFRS-R mean ± SEM first visit | 30.46 ± 1.93 | 48.0 ± 0.0 |
Range, 21–41 | ||
ALSFRS-R mean ± SEM second visit | 27.25 ± 2.73 | N/A |
Range, 21–38 | ||
Disease duration from onset (months) at first visit mean ± SEM | 41.77 ± 7.53 | N/A |
Range, 11–96 | ||
Disease duration from diagnosis (months) at first visit mean ± SEM | 21.00 ± 4.44 | N/A |
Range, 5–53 |